Opioid Relapse Reduction Therapeutics Grant
Brain Research Foundation is announcing a new grant initiative. We invite eligible Principal Investigators to submit a Letter of Intent (LOI) for the Opioid Relapse Reduction Therapeutics Grant by February 28, 2018. To be eligible, the PI must be a full-time tenure-track or tenured faculty at a U.S. institution, working in the area of study of opioid addiction. The goal of this program is to accelerate the development of new relapse reduction therapeutics.
Funding Opportunity Purpose:
The purpose of this request for proposals is to support the development of novel, translational research that will help accelerate the understanding of the mechanisms associated with opioid use disorders and addiction, targeted to medication development for new relapse reduction therapeutics.
The pre-clinical research areas of focus may include (but are not limited to):
- Neurobiology of relapse to drug taking
- Identifying new chemicals for high potential for relapse reduction
- Repurposing of FDA-approved therapies for relapse reduction
- Alternative therapies
- Vulnerability to relapse factors (e.g., genetics, epigenetics, environmental stresses)
Download a PDF version of the Opioid Relapse Reduction Announcement and Guidelines.